Therapy resistance is responsible for tumour recurrence and represents one of the major
challenges in present oncology. Significant advances have been made in the understanding …

The Epithelial-to-Mesenchymal Transition (EMT) is a cell-biological process that operates
during embryonic development, wound-healing, and carcinoma progression. During this …

Metastasis is a significant contributor to morbidity and mortality for many cancer patients and
remains a major obstacle for effective treatment. In many tissue types, metastasis is fueled …

The epithelial-to-mesenchymal transition (EMT) is a process that confers migratory
characteristics to epithelial cells. It is a major force driving embryonic development, tissue …

There are remarkable similarities in the description of cancer stem cells (CSCs) and cancer
cells with mesenchymal phenotype. Both cell types are highly tumorigenic, resistant against …

Simple Summary In this manuscript, we used a non-genetically manipulated EMT/MET cell
line model to demonstrate that epithelial mesenchymal plasticity occurring in normal cells …

Cancer stem cells (CSCs) are similar to normal stem cells in their ability to self‐renew and to
generate large populations of more differentiated descendants. In contrast to the hierarchical …

Metastasis involves multiple cycles of Epithelial-to-Mesenchymal Transition (EMT) and its
reverse-MET. Cells can also undergo partial transitions to attain a hybrid epithelial …

An epithelial-mesenchymal transition (EMT) has been implicated in cancer metastasis, drug
resistance, and in conferring stem cell-like traits to cancer cells. Most studies investigating …

Epithelial plasticity, or epithelial‐to‐mesenchymal transition (EMT), is a well‐recognized
form of cellular plasticity, which endows tumor cells with invasive properties and alters their …